Cargando…

Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study

Little is still known about the clinical features associated with the occurrence of acute respiratory distress syndrome (ARDS) in hospitalized patients with Coronavirus disease 2019 (COVID-19). The aim of the present study was to describe the prevalence of pre-admission antithrombotic therapies in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Russo, Vincenzo, Di Maio, Marco, Attena, Emilio, Silverio, Angelo, Scudiero, Fernando, Celentani, Dario, Lodigiani, Corrado, Di Micco, Pierpaolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256617/ https://www.ncbi.nlm.nih.gov/pubmed/32474087 http://dx.doi.org/10.1016/j.phrs.2020.104965

Ejemplares similares

Pre-admission atrial fibrillation in COVID-19 patients: Prevalence and clinical impact
por: Russo, Vincenzo, et al.
Publicado: (2021)

In vitro Fertilization Procedures with Embryo Transfer and Their Association with Thrombophilia, Thrombosis and Early Antithrombotic Treatments
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

Idiopathic Hypereosinophilia and Venous Thromboembolism: Is There a Pathophysiological or Clinical Link? Description of an Intriguing Clinical Case
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

Venous Thromboembolism and Its Association with COVID-19: Still an Open Debate
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

Fondaparinux and bleeding risk in COVID-19: unsolved question
por: Russo, Vincenzo, et al.
Publicado: (2021)

Antithrombotic and Anti-Inflammatory Effects of Fondaparinux and Enoxaparin in Hospitalized COVID-19 Patients: The FONDENOXAVID Study
por: Cardillo, Giuseppe, et al.
Publicado: (2021)

Prognostic Value of Fibrinogen among COVID-19 Patients Admitted to an Emergency Department: An Italian Cohort Study
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

Clinical Outcome of Hospitalized COVID-19 Patients with History of Atrial Fibrillation
por: Russo, Vincenzo, et al.
Publicado: (2022)

Thrombotic Disorders and Antithrombotic Treatments Special Issue
por: Micco, Pierpaolo Di
Publicado: (2022)

Chronic Oral Anticoagulation and Clinical Outcome in Hospitalized COVID-19 Patients
por: Russo, Vincenzo, et al.
Publicado: (2021)

Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

Pulmonary embolism in COVID-19 patients: prevalence, predictors and clinical outcome
por: Scudiero, Fernando, et al.
Publicado: (2021)

Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study
por: Russo, Vincenzo, et al.
Publicado: (2020)

Clinical Outcome of Edoxaban vs. Vitamin K Antagonists in Patients with Atrial Fibrillation and Diabetes Mellitus: Results from a Multicenter, Propensity-Matched, Real-World Cohort Study
por: Russo, Vincenzo, et al.
Publicado: (2020)

Pathophysiology of Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT) and Vaccine-Induced Thrombocytopenic Thrombosis (VITT) and Their Diagnostic Approach in Emergency
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

Clinical conditions and echocardiographic parameters associated with mortality in COVID‐19
por: Silverio, Angelo, et al.
Publicado: (2021)

Heparin and SARS-CoV-2: Multiple Pathophysiological Links
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

Is there a relationship between factor V Leiden and type 2 diabetes?
por: Lodigiani, Corrado, et al.
Publicado: (2009)

Cardiovascular Comorbidities and Pharmacological Treatments of COVID-19 Patients Not Requiring Hospitalization
por: Russo, Vincenzo, et al.
Publicado: (2020)

Compromised Lung Volume and Hemostatic Abnormalities in COVID-19 Pneumonia: Results from an Observational Study on 510 Consecutive Patients
por: Lanza, Ezio, et al.
Publicado: (2021)

Differences in the INR evaluation of two different thromboplastins in patients with positivity to lupus anticoagulant in ongoing oral anticoagulation
por: Ferrazzi, Paola, et al.
Publicado: (2010)

Prognostic Implications of Right Ventricular Function and Pulmonary Pressures Assessed by Echocardiography in Hospitalized Patients with COVID-19
por: Polito, Maria Vincenza, et al.
Publicado: (2021)

Long-Term Prognostic Impact of Right Ventricular Dysfunction in Patients with COVID-19
por: Scudiero, Fernando, et al.
Publicado: (2022)

Safety and Efficacy of Triple Antithrombotic Therapy with Dabigatran versus Vitamin K Antagonist in Atrial Fibrillation Patients: A Pilot Study
por: Russo, Vincenzo, et al.
Publicado: (2019)

Effect of Triple Combination Therapy With Lopinavir-Ritonavir, Azithromycin, and Hydroxychloroquine on QT Interval and Arrhythmic Risk in Hospitalized COVID-19 Patients
por: Russo, Vincenzo, et al.
Publicado: (2020)

Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B 12 in patients with retinal vein occlusion
por: Ferrazzi, Paola, et al.
Publicado: (2005)

The Impact of Risk-Adjusted Heparin Regimens on the Outcome of Patients with COVID-19 Infection. A Prospective Cohort Study
por: Di Micco, Pierpaolo, et al.
Publicado: (2021)

Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19
por: Corrochano, Mariana, et al.
Publicado: (2021)

Intima-media thickness evolution after treatment with infliximab in patients with rheumatoid arthritis
por: Di Micco, Pierpaolo, et al.
Publicado: (2009)

Pre-admission antithrombotic use is associated with 3-month mRS score after thrombectomy for acute ischemic stroke
por: Krieger, Penina, et al.
Publicado: (2022)

Congenital and acquired thrombotic risk factors in lymphoma patients bearing upper extremities deep venous thrombosis: a preliminary report
por: Di Micco, Pierpaolo, et al.
Publicado: (2004)

Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report
por: Canonico, Mario Enrico, et al.
Publicado: (2022)

Etiology of hypercoagulable state in women with recurrent fetal loss without other causes of miscarriage from Southern Italy: new clinical target for antithrombotic therapy
por: D’Uva, Maristella, et al.
Publicado: (2008)

Antithrombotic treatment patterns in patients with atrial fibrillation in Italy pre- and post-DOACs: the REPAIR study
por: Esposti, Luca D, et al.
Publicado: (2019)

Late Onset Occurrence of Concomitant Myocardial Infarction and Ischemic Stroke in Hospitalized COVID-19 Patient: A Case Report
por: Ianniciello, Antonio, et al.
Publicado: (2022)

Antithrombotic Therapy in Transcatheter Aortic Valve Replacement
por: Valvo, Roberto, et al.
Publicado: (2019)

Risk Assessment and Antithrombotic Strategies in Antiphospholipid Antibody Carriers
por: Calcaterra, Ilenia, et al.
Publicado: (2021)

Blood Targets of Adjuvant Drugs Against COVID19
por: Di Micco, Pierpaolo, et al.
Publicado: (2020)

Covid-19 related stroke: No preventative value of antithrombotic therapy
por: Di Pietro, Martina, et al.
Publicado: (2021)

Pre‐ and post‐stroke oral antithrombotics and mortality in patients with ischaemic stroke
por: García Rodríguez, Luis A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g7823krno4q7fhdgmddv5kh8c6